MedPath

MEGRAL TABS

MEGRAL TABS

Discontinued
DIN Number

00068586

Drug Class

Human

Market Date

Dec 31, 1989

Company
HC

glaxo wellcome inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00068586
AIG Number0303680001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02CA52 ERGOTAMINE, COMBINATIONS EXCL. PSYCHOLEPTICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification12:16.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

CAFFEINEActive
Strength: 100 MG / TAB
Monograph: CAFFEINE
CYCLIZINE HYDROCHLORIDEActive
Strength: 50 MG / TAB
Monograph: CYCLIZINE HYDROCHLORIDE
ERGOTAMINE TARTRATEActive
Strength: 2 MG / TAB
Monograph: ERGOTAMINE TARTRATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.